TEVA

Teva Pharmaceutical Industries Limited

13.50 USD
+0.34 (+2.62%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Teva Pharmaceutical Industries Limited stock is up 11.53% since 30 days ago. The next earnings date is May 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52.94% of the previous 34 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 67% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
27 Feb 20:25 17 Jan, 2025 7.00 CALL 60 2888
28 Feb 14:55 16 Jan, 2026 12.00 CALL 100 661
28 Feb 17:55 21 Jun, 2024 13.00 CALL 300 81516
28 Feb 19:41 01 Mar, 2024 13.00 PUT 4000 15432
29 Feb 17:41 16 Jan, 2026 7.00 CALL 100 2060
01 Mar 16:10 17 Jan, 2025 12.00 CALL 97 10724
01 Mar 16:11 21 Jun, 2024 13.00 CALL 300 81851
01 Mar 16:15 21 Jun, 2024 13.00 CALL 200 81851
01 Mar 17:15 17 Jan, 2025 12.00 CALL 200 10724
01 Mar 19:13 17 Jan, 2025 5.00 CALL 50 1017

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited sells generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. Its products in the central nervous system, pain, respiratory, and oncology areas include Copaxone for the treatment of relapsing forms of multiple sclerosis. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

  • Piper Sandler
    Mon Feb 12, 05:27
    buy
    upgrade
  • Goldman Sachs
    Mon Feb 5, 10:51
    hold
    confirm
  • Barclays
    Mon Feb 5, 08:45
    buy
    confirm